insights_auto
Hvorfor er CHGCY faldet med 4,61%?
Dyk dybere nedchevron_right
CHGCY:OTCMKTS
Chugai Pharmaceutical ADR
20,08 US$
arrow_downward
-4,61%(-0,97) 1D
20,08 US$
0,00% (0,00)
bedtimeEftermarked
Lukket: 28. sep., 16.00.00 GMT-4 · USD
search
Alle symboler
1D
5D
1M
6M
ÅTD
1Å
5Å
MAKS
| Symbol | Pris | Ændring | Ændring i % |
|---|
insights_autoGenererer vigtig indsigt for CHGCY...
Åbn
20,04 US$
Høj
21,05 US$
Lav
19,94 US$
Markedsværdi
10,24 bio.
Gns. vol.
227,71 t
Volumen
373,30 t
Højeste i 52 uger
34,84 US$
Laveste i 52 uger
19,94 US$
Beta
0,57
Aktier i omløb
3,36 mia.
Antal ansatte
5 t
Åbn
20,04 US$
Høj
21,05 US$
Lav
19,94 US$
Markedsværdi
10,24 bio.
Gns. vol.
227,71 t
Volumen
373,30 t
Højeste i 52 uger
34,84 US$
Laveste i 52 uger
19,94 US$
Beta
0,57
Aktier i omløb
3,36 mia.
Antal ansatte
5 t
Nyhedshistorier
Fra webkilder og nyhedspartnere
Investing.com Nigeria
·
for 5 timer siden
Why is Chugai Pharmaceutical stock sliding today? By Investing.com
Investing.com
·
for 5 timer siden
Why is Chugai Pharmaceutical stock sliding today?
TipRanks
·
for 1 dag siden
Chugai Takes Back Rights to Emugrobart as Roche Exits Obesity Program, Revives SMA Focus
Yahoo Finance
·
for 3 dage siden
Chugai Pharmaceutical And 2 Japanese AI Healthcare Stocks To Own
Profil
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
Om Chugai Pharmaceutical ADR
Administrerende direktørOsamu Okuda
Ansatte5,1 t
Grundlagt10. mar. 1925
Hovedsæde-
Sektor-
Websitechugai-pharm.co.jp